<?xml version="1.0" encoding="UTF-8"?>
<ref id="B135-pharmaceuticals-12-00157">
 <label>135.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Mohr</surname>
    <given-names>E.L.</given-names>
   </name>
   <name>
    <surname>McMullan</surname>
    <given-names>L.K.</given-names>
   </name>
   <name>
    <surname>Lo</surname>
    <given-names>M.K.</given-names>
   </name>
   <name>
    <surname>Spengler</surname>
    <given-names>J.R.</given-names>
   </name>
   <name>
    <surname>Bergeron</surname>
    <given-names>É.</given-names>
   </name>
   <name>
    <surname>Albariño</surname>
    <given-names>C.G.</given-names>
   </name>
   <name>
    <surname>Shrivastava-Ranjan</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Chiang</surname>
    <given-names>C.F.</given-names>
   </name>
   <name>
    <surname>Nichol</surname>
    <given-names>S.T.</given-names>
   </name>
   <name>
    <surname>Spiropoulou</surname>
    <given-names>C.F.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Inhibitors of cellular kinases with broad-spectrum antiviral activity for hemorrhagic fever viruses</article-title>
  <source>Antivir. Res.</source>
  <year>2015</year>
  <volume>120</volume>
  <fpage>40</fpage>
  <lpage>47</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2015.05.003</pub-id>
  <pub-id pub-id-type="pmid">25986249</pub-id>
 </element-citation>
</ref>
